166 related articles for article (PubMed ID: 11916789)
1. A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
Vanacker BF; Geerts E; Coppens S; van Iersel M
Anesth Analg; 2002 Apr; 94(4):876-8, table of contents. PubMed ID: 11916789
[TBL] [Abstract][Full Text] [Related]
2. [The time-course of action of rapacuronium and mivacurium after early reversal following equally lasting relaxation].
Geldner G; Lang C; Hoffmann W; Hossfeld A; Weinberger J; Eble M; Blobner M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):594-9. PubMed ID: 12975739
[TBL] [Abstract][Full Text] [Related]
3. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
4. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
5. Rapacuronium bromide: a review of its use in anaesthetic practice.
Onrust SV; Foster RH
Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
[TBL] [Abstract][Full Text] [Related]
7. Rapacuronium: clinical pharmacology.
Mirakhur RK; McCourt KC
Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
[TBL] [Abstract][Full Text] [Related]
8. Duration of action of vecuronium after an intubating dose of rapacuronium, vecuronium, or succinylcholine.
Gan TJ; Madan R; Alexander R; Jhaveri R; El-Moalem H; Weatherwax K; Glass PS
Anesth Analg; 2001 May; 92(5):1199-202. PubMed ID: 11323346
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
[TBL] [Abstract][Full Text] [Related]
10. Rapacuronium: first experience in clinical practice.
Bartkowski RR; Witkowski TA
Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular effects of rapacuronium in pediatric patients during nitrous oxide-halothane anesthesia: comparison with mivacurium.
Brandom BW; Margolis JO; Bikhazi GB; Ross AK; Ginsberg B; Dear G; Kenaan CA; Eck JB; Woelfel SK; Lloyd ME
Can J Anaesth; 2000 Feb; 47(2):143-9. PubMed ID: 10674508
[TBL] [Abstract][Full Text] [Related]
12. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
[TBL] [Abstract][Full Text] [Related]
13. The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium.
Szenohradszky J; Lau M; Brown R; Sharma ML; Fisher DM
Anesthesiology; 1995 Jul; 83(1):83-7. PubMed ID: 7605023
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
[TBL] [Abstract][Full Text] [Related]
16. Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.
Blobner M; Mirakhur RK; Wierda JM; Wright PM; Olkkola KT; Debaene B; Pendeville P; Engbaek J; Rietbergen H; Sparr HJ
Br J Anaesth; 2000 Nov; 85(5):724-31. PubMed ID: 11094588
[TBL] [Abstract][Full Text] [Related]
17. Early reversal of rapacuronium with neostigmine.
Purdy R; Bevan DR; Donati F; Lichtor JL
Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
Fleming NW; Lewis BK
Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous recovery or evoked reversal of neuromuscular block.
Mirakhur RK
Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
[TBL] [Abstract][Full Text] [Related]
20. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
